Early time-dependent dynamic changes of TBET and GATA3 mRNA expressions in patients with acute coronary syndrome

Disease Markers

Volumn 35, Issue 5, 2013, Pages 419-429

  Rainer, Timothy H ^a   Graham, Colin A ^a   Chan, Rebecca W Y ^b   Chan, Cangel P Y ^a   Tan, Patrick C F ^a   Yip, Gabriel W K ^b   Yu, Cheuk Man ^b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; TROPONIN T; VASODILATOR AGENT; WARFARIN;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; AGED; ANALYTICAL EQUIPMENT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAM; EMERGENCY WARD; EPIGASTRIC PAIN; FEMALE; GENE EXPRESSION; HEART LEFT BUNDLE BRANCH BLOCK; HEART MUSCLE ISCHEMIA; HOUSEKEEPING GENE; HUMAN; MALE; MIDDLE AGED; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OBSERVATIONAL STUDY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REST; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STABLE ANGINA PECTORIS; T WAVE INVERSION; THORAX PAIN; UNSTABLE ANGINA PECTORIS; VERY ELDERLY;

ACUTE CORONARY SYNDROME; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; GATA3 TRANSCRIPTION FACTOR; HUMANS; KINETICS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; RNA, MESSENGER; T-BOX DOMAIN PROTEINS;

EID: 84890386626     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2013/139895     Document Type: Article

References (29)

1. W.-P. Zheng and R. A. Flavell, "The transcription factor GATA-3 is necessary and sufficient forTh2 cytokine gene expression in CD4 T cells," Cell, vol. 89, no. 4, pp. 587-596, 1997.
2. S. J. Szabo, S. T. Kim, G. L. Costa, X. Zhang, C. G. Fathman, and L. H. Glimcher, "A novel transcription factor, T-bet, directs Th1 lineage commitment," Cell, vol. 100, no. 6, pp. 655-669, 2000.
3. K.M.Murphy and S. L. Reiner, "The lineage decisions of helper T cells," Nature Reviews Immunology, vol. 2, no. 12, pp. 933-944, 2002.
4. S. J. Szabo, B. M. Sullivan, S. L. Peng, and L. H. Glimcher, "Molecular mechanisms regulating Th1 immune responses," Annual Review of Immunology, vol. 21, pp. 713-758, 2003.
5. E. Laurat, B. Poirier, E. Tupin et al., "In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice," Circulation, vol. 104, no.2,pp. 197-202, 2001.
6. H. Methe, S. Brunner, D. Wiegand, M. Nabauer, J. Koglin, and E. R. Edelman, "Enhanced T-helper-1 lymphocyte activation patterns in acute coronary syndromes," Journal of the American College of Cardiology, vol. 45, no. 12, pp. 1939-1945, 2005.
7. M. Fisher and E. Folland, "Acute ischemic coronary artery disease and ischemic stroke: similarities and differences,"American Journal ofTherapeutics, vol. 15, no. 2, pp. 137-149, 2008.
8. Q.-W. Ji,M. Guo, J.-S. Zheng et al., "Downregulation of T helper cell type 3 in patients with acute coronary syndrome," Archives of Medical Research, vol. 40, no. 4, pp. 285-293, 2009.
9. H. Soejima, A. Irie, S. Miyamoto et al., "Preference toward a Thelper type 1 response in patients with coronary spastic angina," Circulation, vol. 107, no. 17, pp. 2196-2200, 2003.
10. G. B. Sajan, T. Z. Qiu, X. Wang, and H.-P. Guo, "T helper cell related interleukins and the angiographic morphology in unstable angina," Cytokine, vol. 30, no. 5, pp. 303-310, 2005.
11. H. Yamashita, K. Shimada, E. Seki, H. Mokuno, and H. Daida, "Concentrations of interleukins, interferon, and C-reactive protein in stable and unstable angina pectoris," American Journal of Cardiology, vol. 91, no. 2, pp. 133-136, 2003.
12. X. Cheng, Y.-H. Liao, H. Ge et al., "Th1/Th2 functional imbalance after acutemyocardial infarction: coronary arterial inflammation or myocardial inflammation," Journal of Clinical Immunology, vol. 25, no. 3, pp. 246-253, 2005.
13. A. Adler, Y. Levy, A. Roth, D. Wexler, G. Keren, and J. George, "Functional T-lymphocyte dichotomy in the peripheral blood of patients with unstable angina," International Journal of Cardiovascular Interventions, vol. 7, no. 3, pp. 146-151, 2005.
14. T. H. Rainer, R. W. Y. Chan, C. A. Graham et al., "Circulating leukocyte TBET and GATA3 mRNA in patients with acute coronary syndrome," International Journal of Cardiology, vol. 156, no. 2, pp. 209-211, 2012.
15. J. L. Anderson, C. D. Adams, E. M. Antman et al., "ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society ofThoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic EmergencyMedicine," Journal of the American College of Cardiology, vol. 50, no. 7, pp. e1-e157, 2007.
16. K. Thygesen, J. S. Alpert, and H. D. White, "Joint ESC/ACCF/ AHA/WHF task force for the redefinition ofmyocardial Infarction. Universal definition ofmyocardial infarction2007," Journal of the American College of Cardiology, vol. 50, pp. 2173-2195, 2007.
17. E.M. Antman, D. T. Anbe, P.W. Armstrong et al., "ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction)," Circulation, vol. 110, no. 9, pp. e82-e292, 2004.
18. G. W. Snedecor and W. G. Cochran, Statistical Methods, The Iowa StateUniversity Press, Ames, Iowa,USA, 6th edition, 1971.
19. G. K. Hansson, "Immunemechanisms in atherosclerosis," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 21, pp. 1876-1890, 2001.
20. P. Libby, "Current concepts of the pathogenesis of the acute coronary syndromes," Circulation, vol. 104, no. 3,pp. 365-372, 2001.
21. G. J. Blake and P. M. Ridker, "Novel clinical markers of vascular wall inflammation," Circulation Research, vol. 89, no. 9, pp. 763-771, 2001.
22. L. Lind, "Circulating markers of inflammation and atherosclerosis," Atherosclerosis, vol. 169, no. 2, pp. 203-214, 2003.
23. L. M. Biasucci, "CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: application to Clinical and Public Health Practice: clinical use of inflammatory markers in patients with cardiovascular diseases: a background paper," Circulation, vol. 110, no. 25, pp. e560-e567, 2004.
24. S. J. Szabo, B. M. Sullivan, C. Sternmann, A. R. Satoskar, B. P. Sleckman, and L. H. Glimcher, "Distinct effects of T-bet inTh1 lineage commitment and IFN-α production in CD4 and CD8 T cells," Science, vol. 295, no. 5553, pp. 338-342, 2002.
25. P. R.Moreno, E. Falk, I. F. Palacios, J. B. Newell, V. Fuster, and J. T. Fallon, "Macrophage infiltration in acute coronary syndromes: implications for plaque rupture," Circulation, vol. 90, no. 2, pp. 775-778, 1994.
26. E. Lantelme, S. Mantovani, B. Palermo, R. Campanelli, F. Sallusto, and C. Giachino, "Kinetics of GATA-3 gene expression in early polarizing and committed human T cells," Immunology, vol. 102, no. 2, pp. 123-130, 2001.
27. H. J. Lee, N. Takemoto, H. Kurata et al., "GATA-3 induces T helper cell type 2 (Th2) cytokine expression and chromatin remodeling in committed Th1 cells," Journal of Experimental Medicine, vol. 192, no. 1, pp. 105-115, 2000.
28. J. L. Fernandes, R. L.Mamoni, J. L. Orford et al., "IncreasedTh1 activity in patients with coronary artery disease," Cytokine, vol. 26, no. 3, pp. 131-137, 2004.
29. H. Chakir, H. Wang, D. E. Lefebvre, J. Webb, and F. W. Scott, "T-bet/GATA-3 ratio as a measure of the Th1/Th2 cytokine profile in mixed cell populations: Predominant role ofGATA-3," Journal of ImmunologicalMethods, vol. 278, no. 1-2, pp. 157-169, 2003.